Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Recent Advances in Inflammation & Allergy Drug Discovery
  4. Fast Track Articles
  5. Fast Track Article
image of Neutrophil-lymphocyte, Lymphocyte-monocyte, and Platelet-lymphocyte Ratios: Non-invasive Biomarkers for Assessing Inflammatory Bowel Disease Activity

Abstract

Background

Inflammatory bowel diseases (IBD) necessitate cost-effective biomarkers for efficient management. This study aimed to explore the potential correlations of neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) with IBD disease activity. Additionally, we assessed their associations with other inflammatory markers.

Methods

We recruited 180 IBD patients with over 12 months of disease duration, categorized into two groups: Group 1 (active IBD) with 113 cases and Group 2 (inactive IBD) with 67 cases, alongside 200 group-matched healthy controls (Group 3). Hemogram, NLR, LMR, PLR, hs-CRP, ESR, fecal calprotectin (FC), and relevant parameters were recorded.

Results

NLR and PLR were elevated, while LMR was decreased in active IBD patients compared to those in remission. The cutoff values for active IBD were determined as NLR > 1.98, LMR < 3.01, and PLR > 147, exhibiting sensitivity of 92%, 88%, and 91%, and specificity of 93%, 87%, and 89% respectively. Optimal cutoff values for IBD disease activity were CRP > 9.71, ESR > 24, and FC > 176. Multivariate logistic regression identified NLR, LMR, and PLR as robust parameters for discriminating IBD disease activity after adjusting for WBC, CRP, ESR, and FC markers ( < 0.05). NLR and PLR exhibited proportional increases with IBD severity, while LMR lacked such predictive capability.

Conclusions

NLR, PLR, and LMR emerge as simple, non-invasive, and cost-effective independent markers of IBD disease activity, complementing traditional markers like CRP and ESR.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/raiad/10.2174/0127722708330712241106074203
2024-12-04
2025-01-20

  • From This Site

    /content/journals/raiad/10.2174/0127722708330712241106074203
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Feng W. Liu Y. Zhu L. Xu L. Shen H. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential markers for ulcerative colitis: A retrospective study. BMC Gastroenterol. 2022 22 1 485 10.1186/s12876‑022‑02571‑9 36424535
    [Google Scholar]
  2. Langley B.O. Guedry S.E. Goldenberg J.Z. Hanes D.A. Beardsley J.A. Ryan J.J. Inflammatory bowel disease and Neutrophil–Lymphocyte ratio: A systematic scoping review. J. Clin. Med. 2021 10 18 4219 10.3390/jcm10184219 34575330
    [Google Scholar]
  3. Rubin D.T. Ananthakrishnan A.N. Siegel C.A. Sauer B.G. Long M.D. ACG clinical guideline: Ulcerative colitis in adults. Am. J. Gastroenterol. 2019 114 3 384 413 10.14309/ajg.0000000000000152 30840605
    [Google Scholar]
  4. Günay E. Sarınç Ulaşlı S. Akar O. Ahsen A. Günay S. Koyuncu T. Ünlü M. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: A retrospective study. Inflammation 2014 37 2 374 380 10.1007/s10753‑013‑9749‑1 24078279
    [Google Scholar]
  5. Targońska-Stępniak B Zwolak R Piotrowski M The relationship between hematological markers of systemic inflammation (Neutrophil-To-Lymphocyte, platelet-To-Lymphocyte, Lymphocyte-To-Monocyte Ratios) and ultrasound disease activity parameters in patients with rheumatoid arthritis. J Clin Med. 2020 9 9 2760
    [Google Scholar]
  6. e W. Wang Z. Pang M. Lu Y. Fan H. The correlation between platelet-to-lymphocyte ratio and Neutrophil-to-Lymphocyte ratio with Hepatic Echinococcosis. J. Inflamm. Res. 2021 14 14 2403 2409 10.2147/JIR.S304307 34113147
    [Google Scholar]
  7. Qin B. Ma N. Tang Q. Wei T. Yang M. Fu H. Hu Z. Liang Y. Yang Z. Zhong R. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod. Rheumatol. 2016 26 3 372 376 10.3109/14397595.2015.1091136 26403379
    [Google Scholar]
  8. Khan R. Quaiser S. Correlation of neutrophil–lymphocyte ratio with disease activity in rheumatoid arthritis. J Clin Sci. 2020 17 2 46 48 10.4103/jcls.jcls_16_18
    [Google Scholar]
  9. Yao C. Liu X. Tang Z. Prognostic role of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio for hospital mortality in patients with AECOPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2017 12 2285 2290 10.2147/COPD.S141760 28814856
    [Google Scholar]
  10. Pan L Du J Li T Liao H Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: A case-control study. BMJ Open. 2017 7 4 e014451 10.1136/bmjopen‑2016‑014451
    [Google Scholar]
  11. Diem S. Schmid S. Krapf M. Flatz L. Born D. Jochum W. Templeton A.J. Früh M. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer 2017 111 176 181 10.1016/j.lungcan.2017.07.024 28838390
    [Google Scholar]
  12. Weng W. Chen X. Gong S. Guo L. Zhang X. Preoperative neutrophil–lymphocyte ratio correlated with glioma grading and glioblastoma survival. Neurol. Res. 2018 40 11 917 922 10.1080/01616412.2018.1497271 30074469
    [Google Scholar]
  13. Stephanie L. Gold B.L. Gordon Y. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR): Novel predictors of disease activity in patients with inflammatory bowel disease. Gastroenterol. 2020 158 6 S-703 10.1016/S0016‑5085(20)32448‑3
    [Google Scholar]
  14. Argeny S. Stift A. Bergmann M. Mittlböck M. Maschke S. Yang Y. Chitsabesan P. Riss S. Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn’s disease. Wien. Klin. Wochenschr. 2018 130 11-12 398 403 10.1007/s00508‑018‑1322‑3 29435759
    [Google Scholar]
  15. Celikbilek M. Dogan S. Ozbakır O. Zararsız G. Kücük H. Gürsoy S. Yurci A. Güven K. Yücesoy M. Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J. Clin. Lab. Anal. 2013 27 1 72 76 10.1002/jcla.21564 23292894
    [Google Scholar]
  16. Akpinar MY Ozin YO Kaplan M Platelet-to-lymphocyte ratio and Neutrophil-to-lymphocyte ratio predict mucosal disease severity in ulcerative colitis. J Med Biochem. 2018 37 2 155 162
    [Google Scholar]
  17. Xu M Cen M Chen X Correlation between serological biomarkers and disease activity in patients with inflammatory bowel disease. Biomed Res Int. 2019 2019 6517549 10.1155/2019/6517549
    [Google Scholar]
  18. Yamamoto-Furusho J.K. Mendieta-Escalante E.A. Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative Colitis. PLoS One 2020 15 4 e0231988 10.1371/journal.pone.0231988 32315368
    [Google Scholar]
  19. Torun S. Tunc B.D. Suvak B. Yildiz H. Tas A. Sayilir A. Ozderin Y.O. Beyazit Y. Kayacetin E. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: A promising marker in predicting disease severity. Clin. Res. Hepatol. Gastroenterol. 2012 36 5 491 497 10.1016/j.clinre.2012.06.004 22841412
    [Google Scholar]
  20. Acarturk G. Acay A. Demir K. Ulu M.S. Ahsen A. Yuksel S. Neutrophil-to-lymphocyte ratio in inflammatory bowel disease – As a new predictor of disease severity. Bratisl. Med. J. 2015 116 4 213 217 10.4149/BLL_2015_041 25773946
    [Google Scholar]
  21. Jeong Y. Jeon S.R. Kim H.G. Moon J.R. Lee T.H. Jang J.Y. Cho J.H. Park J.S. Park H. Lee K. Kim J.O. Lee J.S. Ko B.M. Park S. The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis. Intest. Res. 2021 19 1 62 70 10.5217/ir.2019.09156 32375208
    [Google Scholar]
  22. Fidan K. Kocak M.Z. Assessment of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ulcerative colitis: A retrospective study. Eurasian J. Med. Oncol. 2017 1 4 224 227
    [Google Scholar]
  23. Demir A.K. Demirtas A. Kaya S.U. Tastan I. Butun I. Sagcan M. Sahin S. Tasliyurt T. Yilmaz A. The relationship between the neutrophil–lymphocyte ratio and disease activity in patients with ulcerative colitis. Kaohsiung J. Med. Sci. 2015 31 11 585 590 10.1016/j.kjms.2015.10.001 26678939
    [Google Scholar]
  24. Okba AM Amin MM Abdelmoaty AS Neutrophil/lymphocyte ratio and lymphocyte/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severity. Auto Immun Highlights. 2019 10 1 4 10.1186/s13317‑019‑0114‑8 32257060
    [Google Scholar]
  25. Kolaczkowska E. Kubes P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 2013 13 3 159 175 10.1038/nri3399 23435331
    [Google Scholar]
  26. Rodríguez-Perlvárez M.L. García-Sánchez V. Villar-Pastor C.M. González R. Iglesias-Flores E. Muntane J. Gómez-Camacho F. Role of serum cytokine profile in ulcerative colitis assessment. Inflamm. Bowel Dis. 2012 18 10 1864 1871 10.1002/ibd.22865 22238172
    [Google Scholar]
  27. Zhou G.X. Liu Z.J. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease. J. Dig. Dis. 2017 18 9 495 503 10.1111/1751‑2980.12540 28857501
    [Google Scholar]
  28. Naito Y. Takagi T. Yoshikawa T. Neutrophil-dependent oxidative stress in ulcerative colitis. J. Clin. Biochem. Nutr. 2007 41 1 18 26 10.3164/jcbn.2007003 18392100
    [Google Scholar]
  29. Chen Y.H. Wang L. Feng S.Y. Cai W.M. Chen X.F. Huang Z.M. The relationship between C-Reactive protein/Albumin ratio and disease activity in patients with inflammatory bowel disease. Gastroenterol. Res. Pract. 2020 2020 1 8 10.1155/2020/3467419 32655630
    [Google Scholar]
  30. Furukawa S Yagi S Shiraishi K Association between platelet count and mucosal healing in Japanese patients with ulcerative colitis: A cross-sectional study. BMC Gastroenterol. 2020 20 1 384 10.1186/s12876‑020‑01538‑y
    [Google Scholar]
  31. Öztürk ZA Dag MS Kuyumcu ME Could platelet indices be new biomarkers for inflammatory bowel diseases? Eur Rev Med Pharmacol Sci. 2013 17 3 334 341
    [Google Scholar]
  32. Nakarai A Kato J Hiraoka S An elevated platelet count increases the risk of relapse in Ulcerative Colitis patients with Mucosal healing. Gut Liver. 2018 12 4 420 425 10.5009/gnl17236
    [Google Scholar]
  33. Lee S.H. Kim M.J. Chang K. Song E.M. Hwang S.W. Park S.H. Yang D.H. Kim K.J. Byeon J.S. Myung S.J. Yang S.K. Ye B.D. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis. BMC Gastroenterol. 2017 17 1 110 10.1186/s12876‑017‑0669‑7 29061121
    [Google Scholar]
  34. Takashima S. Kato J. Hiraoka S. Nakarai A. Takei D. Inokuchi T. Sugihara Y. Takahara M. Harada K. Okada H. Tanaka T. Yamamoto K. Evaluation of Mucosal healing in ulcerative colitis by Fecal Calprotectin Vs. Fecal immunochemical test. Am. J. Gastroenterol. 2015 110 6 873 880 10.1038/ajg.2015.66 25823769
    [Google Scholar]
  35. Cherfane C.E. Gessel L. Cirillo D. Zimmerman M.B. Polyak S. Monocytosis and a low lymphocyte to monocyte ratio are effective biomarkers of Ulcerative Colitis disease activity. Inflamm. Bowel Dis. 2015 21 8 1769 1775 10.1097/MIB.0000000000000427 25993688
    [Google Scholar]
/content/journals/raiad/10.2174/0127722708330712241106074203
Loading
Neutrophil-lymphocyte, Lymphocyte-monocyte, and Platelet-lymphocyte Ratios: Non-invasive Biomarkers for Assessing Inflammatory Bowel Disease Activity
Bentham Science Publishers ; https://doi.org/10.2174/0127722708330712241106074203
/content/journals/raiad/10.2174/0127722708330712241106074203
/content/journals/raiad/10.2174/0127722708330712241106074203
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: Neutrophil-lymphocyte ratio ; Crohn's disease ; lymphocyte-monocyte ratio ; platelet-lymphocyte ratio ; inflammatory bowel disease ; ulcerative colitis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test